Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
This analysis evaluates the progression of Alzheimer disease (AD) severity and compares the life expectancy and nursing home placement rates for AD patients with the same measures in the general population. Data from the Consortium to Establish a Registry for Alzheimer Disease were analyzed to estimate expected survival, time spent in each Clinical Dementia Rating stage, and nursing home admission rate for a hypothetical cohort of patients aged 70 years with new-onset AD. Corresponding estimates for the US general population were calculated from the 2004 National Nursing Home Survey and the 2003 life table estimates from the US Census Bureau. Deaths from all causes by age 80 years are expected in 61% of AD patients and in 30% of the general population. From the age of 70 to 80 years, a typical AD patient spends 4 years at Clinical Dementia Rating stage 3 (severe), 3 years at stage 2 (moderate), and 3 years at stage 1 (mild). Nursing home admission by the age of 80 years is expected for approximately 75% of surviving AD patients, but for only 4% of the general population. Among persons aged > or =65 years, reported age-adjusted and sex-adjusted mortality rates for AD increased to 33% from 1999 to 2004.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“among people age 70, 61% of those with Alzheimer's dementia are expected to die before age 80 compared with 30% of people without Alzheimer's dementia.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [384]
In the citing paper
“At age 80, approximately 75% of people with Alzheimer's dementia live in a nursing home compared with only 4% of the general population age 80. 384”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [384]
In the citing paper
“A person who lives from age 70 to age 80 with Alzheimer's dementia will spend an average of 40% of this time in the severe stage.384”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [384]
In the citing paper
“among people age 70, 61% of those with Alzheimer's dementia are expected to die before age 80 compared with 30% of people without Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [414]
In the citing paper
“A person who lives from age 70 to age 80 with Alzheimer's dementia will spend an average of 40% of this time in the severe stage.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [414]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370 · cited 11×
“A substantial impact on life expectancy is manifested early in the course of AD.”
BackgroundInfluentialSelf-citationThe incidence of dementia: A meta-analysis
Jorm, A. F., & Jolley, D. (1998) · Neurology · doi:10.1212/wnl.51.3.728 · Cited by 903
Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603
Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease
Mittelman, M. S., Haley, W. E., Clay, O. J., & Roth, D. L. (2006) · Neurology · doi:10.1212/01.wnl.0000242727.81172.91 · Cited by 602 · cited 1×
“Improving availability of and access to caregiver support and home care services may reduce the need for patient care in institutionalized settings.(41) FIGURE 1.”
BackgroundSurvival after Initial Diagnosis of Alzheimer Disease
Larson, E. B., Shadlen, M.-F., Wang, L., McCormick, W. C., Bowen, J. D., Teri, L., & Kukull, W. A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00008 · Cited by 543
Seshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489 · cited 2×
“In contrast, the corresponding risk for developing AD is nearly 12%.(43) Among men aged 70 years, the remaining lifetime risk for developing prostate cancer is 12%, with the corresponding AD risk being lower, at 6%.”
BackgroundMorris, J. C., McKeel, D. W., Storandt, M., Rubin, E. H., Price, J. L., Grant, E. A., Ball, M. J., & Berg, L. (1991) · Neurology · doi:10.1212/wnl.41.4.469 · Cited by 473
Survival Following a Diagnosis of Alzheimer Disease
Brookmeyer, R., Corrada, M. M., Curriero, F. C., & Kawas, C. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1764 · Cited by 407 · cited 12×
“A substantial impact on life expectancy is manifested early in the course of AD.”
BackgroundInfluentialUnited States life tables, 2003.
Arias, E. (2006) · PubMed · Cited by 375
Alzheimer Disease and Mortality: A 15-Year Epidemiological Study
Ganguli, M., Dodge, H. H., Shen, C., Pandav, R. S., & DeKosky, S. T. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.779 · Cited by 297
Cited by
Items 101–130 of 130
Transitions in Care for the Person with Dementia
Boltz, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-18377-0_14 · Cited by 1
Yuyama, E. K. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-08092021-134129 · Cited by 1
Sanders, C., Matyi, J., Tschanz, J. T., & Andersen, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-56782-2_489-2 · Cited by 1
Azouz, M. (2019) · theses.fr (ABES) · doi:10.70675/4c3b6c12z1da5z497cz9e34zea6e6bf189d9 · Cited by 2
Services for People with Severe Dementia
Black, B. S., & Rabins, P. V. (2013) · Wiley eBooks · doi:10.1002/9781118378663.ch7 · Cited by 2
La mémantine dans la maladie d'Alzheimer : Repousser le placement en CHSLD
Bouchard, R. W. (2009)
Neuroleptiques : le scandale n’est pas là où on le croit…
Wong, C., Cretu, L., & Gomas, J.-M. (2015) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2015.07.005
Pérez, B. M. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/15974 · Cited by 1
Alzheimer’s Disease Mortality and Patient Retention in Clinical Trials
Arrighi, H. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-411464-7.00011-0
Self-citationEnd-Stage Care of Persons with Alzheimer’s Disease
M., K. Y., & Mckenzie, R. R. (2017) · Hospice and Palliative Medicine International Journal · doi:10.15406/hpmij.2017.01.00004
Assessing Cognition In A Mouse Model Of Alzheimer’s Disease
Mels, J. (2018) · Scholarship@Western (Western University) · Cited by 1
Kasi, P. B. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10053
Current awareness in geriatric psychiatry
(2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2397
Burke, A. D., Hall, G. R., Yaari, R., Fleisher, A., Dougherty, J., Young, J., Brand, H., & Tariot, P. N. (2015) · doi:10.1007/978-1-910315-22-4_1
Sanders, C., Matyi, J., Tschanz, J. T., & Andersen, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_489
(2017) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000022
“AD is a gradual, progressive neurodegenerative condition commonly accompanied by chronic medical comorbidities including heart failure, ischemic heart disease, and diabetes [10].”
BackgroundFink, A., Demuth, I., & Doblhammer, G. (2021) · Research Square · doi:10.21203/rs.3.rs-538620/v2
The Lived Experience of Advanced Dementia - Literature ReviewPreprint
Kinnaird, L., Russ, T. C., & Wilkinson, H. A. (2025) · SocArXiv (OSF Preprints) · doi:10.31235/osf.io/zgspm_v1
Huang, X., Xu, Y., Liao, R., Zhao, Q., Lv, X., Liu, Q., Li, L., Ji, Q., Tian, D., Wang, Y., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70229
Snyder, C. (2015) · Digital Commons - USU (Utah State University) · doi:10.26076/8304-1e82 · Cited by 4
Fink, A., Dörre, A., Demuth, I., & Doblhammer, G. (2022) · Figshare · doi:10.6084/m9.figshare.19654663
Sutnikiene, V., Audronytė, E., Pakulaite-Kazliene, G., & Kaubrys, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-33126-z
Exposition aux endotoxines : influence de l'alimentation et rôle dans le vieillissement cognitif
André, P. (2020) · theses.fr (ABES) · doi:10.70675/ea1360c2zd962z46f5zaabfzcbc15c0efc25
Mental health and cognitive function during growing up and in later life
Zhou, Y. (2024) · Ros Dok Rostocker Dokumentenserver (Universitätsbibliothek Rostock) · doi:10.18453/rosdok_id00005301
Li, X., Zhao, W., Zhou, J., & Qiu, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1878852
“The evidence obtained from this group may provide complementary insights into the relationship between uric acid levels and cognitive function within the context of multimorbidity and cognitive decline (9, 10).”
A multimodal investigation of perceptual awareness in Alzheimer’s diseasePreprint
Huntley, J. D., Barnett, B., Bor, D., Mancuso, M., Mediano, P. A. M., Naçi, L., Fleming, S. M., Bertazzoli, G., Clare, L., Owen, A. M., et al. (2026) · medRxiv · doi:10.64898/2026.08.27.26356661
Metadata
- Authors
- Arrighi, H. M., Neumann, P. J., Lieberburg, I. M., & Townsend, R. J.
- Affiliations
- Elan Pharmaceuticals, Inc. (Ireland) (IE)
- Tufts Medical Center (US)
- University of California, San Francisco (US)
- Corresponding author
- Arrighi, Henry Michael
- Lieberburg, Ivan M.
- Townsend, Raymond J.
- ORCID
- Neumann, Peter J.
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2010-01
- Volume
- 24
- Issue
- 1
- Pages
- 90-95
- ISSN
- 0893-0341 (ISSN-L)
- OpenAlex
- W2094938161
- Cited by
- 126
- References
- 36
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 4
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alzheimer Disease & Associated Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, mortality, nursing home admission, life expectancy, Clinical Dementia Rating, disease progression, survival estimates, mortality trends, older adults
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Homes for the Aged, Humans, Life Expectancy, Male, Nursing Homes, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.